Drug intelligence / Profile preview

hRPGRstb

Development stage
Preclinical
Lead developer
Syncona
Modality
Gene Therapies
Administration
Ophthalmic
01

Overview

hRPGRstb is an investigational **gene therapy transgene construct** consisting of a stabilized, truncated version of the human **retinitis pigmentosa GTPase regulator** gene designed for treatment of **X-linked retinitis pigmentosa** caused by **RPGR** mutations. It has been developed by **AGTC** for delivery in recombinant AAV ocular gene therapy vectors, including vectors using the proprietary **AAV2tYF** capsid and a **GRK1** photoreceptor-directed promoter. The stabilization strategy removes repetitive regions that can cause sequence instability during vector engineering and manufacturing, while preserving therapeutic RPGR function. Its intended mechanism is **gene replacement**, restoring RPGR expression in retinal photoreceptors to slow or prevent degeneration of rods and cones and preserve vision.

Other names
stabilized truncated human RPGR transgenestabilized truncated human retinitis pigmentosa GTPase regulator gene
02

Targets

RPGR (Retinitis pigmentosa GTPase regulator)

Beyond the preview

Go deeper on hRPGRstb.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hRPGRstb.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call